Clinical & Experimental Allergy

The Editor takes a closer look at some of this month's articles
pp. 1411-1411(1)

Is there an in vitro test for type IV allergy discriminating between sensitization and allergic disease?
pp. 1412-1415(4)
Authors: Traidl-Hoffmann, C.; Ring, J.

Deficient interferon in virus-induced asthma exacerbations
pp. 1416-1418(3)
Authors: Edwards, M. R.; Johnston, S. L.

The allergic march in early childhood and beyond
pp. 1419-1421(3)
Author: Linneberg, A.

Control of cytokine gene transcription in Th1 and Th2 cells
pp. 1422-1431(10)
Authors: Bowen, H.; Kelly, A.; Lee, T.; Lavender, P.

Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined
pp. 1432-1450(19)
Authors: Sala-Vila, A.; Miles, E. A.; Calder, P. C.

Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids
pp. 1451-1458(8)
Authors: Weatherall, M.; James, K.; Clay, J.; Perrin, K.; Masoli, M.; Wijesinghe, M.; Beasley, R.

Type III IFN-λ mRNA expression in sputum of adult and school-aged asthmatics
pp. 1459-1467(9)
Authors: Bullens, Dominique M. A.; Decraene, A.; Dilissen, E.; Meyts, I.; De Boeck, K.; Dupont, L. J.; Ceuppens, J. L.

Detection of chromium allergy by cellular in vitro methods
pp. 1468-1475(8)
Authors: Lindemann, M.; Rietschel, F.; Zabel, M.; Grosse-Wilde, H.

Localization and function of histamine H₃ receptor in the nasal mucosa
pp. 1476-1482(7)
Authors: Suzuki, S.; Takeuchi, K.; Majima, Y.

Exposure to environmental bacteria may have differing effects on tumour necrosis factor-α and interleukin-6-producing capacity in infancy
pp. 1483-1492(10)
Authors: Lappalainen, M. H. J.; Roponen, M.; Hyvärinen, A.; Nevalainen, A.; Laine, O.; Pekkanen, J.; Hirvonen, M.-R.

Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects
pp. 1493-1498(6)
Authors: Raap, U.; Deneka, N.; Bruder, M.; Kapp, A.; Wedi, B.

Up-regulated cytokine-inducible SH2-containing protein expression in allergen-stimulated T cells from hen's egg-allergic patients
pp. 1499-1506(8)
Authors: Nakajima, Y.; Tsuge, I.; Kondo, Y.; Komatsubara, R.; Hirata, N.; Kakami, M.; Kato, M.; Kurahashi, H.; Urisu, A.; Asano, Y.

Sensitization to inhalant allergens between 4 and 8 years of age is a dynamic process: results from the BAMSE birth cohort
pp. 1507-1513(7)
Authors: Asarnoj, A.; Östblom, E.; Kull, I.; Lilja, G.; Pershagen, G.; Hedlin, G.; van Hage, M.; Wickman, M.

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives
pp. 1514-1525(12)
Authors: Purohit, A.; Niederberger, V.; Kronqvist, M.; Horak, F.; Grönneberg, R.; Suck, R.; Weber, B.; Fiebig, H.; van Hage, M.; Pauli, G.; Valenta, R.; Cromwell, O.

Bakery flour dust exposure causes non-allergic inflammation and enhances allergic airway inflammation in mice
pp. 1526-1535(10)
Authors: Marraccini, P.; Brass, D. M.; Hollingsworth, J. W.; Maruoka, S.; Garantziotis, S.; Schwartz, D. A.

Adenosine receptor subtypes in the airways responses to 5′-adenosine monophosphate inhalation of sensitized guinea-pigs
pp. 1536-1547(12)
Authors: Smith, N.; Broadley, K. J.

Loss of classical transient receptor potential 6 channel reduces allergic airway response
pp. 1548-1558(11)
Authors: Sel, S.; Rost, B. R.; Yildirim, A. Ö.; Sel, B.; Kalwa, H.; Fehrenbach, H.; Renz, H.; Gudermann, T.; Dietrich, A.

Immunochemical characterization of Glycine max L. Merr. var Raiden, as a possible hypoallergenic substitute for cow's milk-allergic patients
pp. 1559-1565(7)
Authors: Curciarello, R.; Lareu, J. F.; Fossati, C. A.; Docena, G. H.; Petruccelli, S.

Forthcoming meetings
pp. 1566-1566(1)